European Union - English - EMA (European Medicines Agency)

recordati netherlands b.v. - siltuximab - giant lymph node hyperplasia - immunosuppressants - sylvant is indicated for the treatment of adult patients with multicentric castleman’s disease (mcd who are human immunodeficiency virus (hiv) negative and human herpesvirus-8 (hhv-8) negative.,

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - siltuximab - powder for solution for infusion - 400mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - siltuximab - powder for solution for infusion - 100mg

Israel - English - Ministry of Health

medison pharma ltd - siltuximab - powder for concentrate for solution for infusion - siltuximab 100 mg - siltuximab - sylvant is indicated for the treatment of adult patients with multicentric castleman’s disease (mcd) who are human immunodeficiency virus (hiv) negative and human herpesvirus-8 (hhv-8) negative.

Canada - English - Health Canada

eusa pharma (uk) limited - siltuximab - powder for solution - 100mg - siltuximab 100mg - immunosuppressive agents

Canada - English - Health Canada

eusa pharma (uk) limited - siltuximab - powder for solution - 400mg - siltuximab 400mg - immunosuppressive agents

Singapore - English - HSA (Health Sciences Authority)

link healthcare singapore pte ltd - siltuximab - injection, powder, lyophilized, for solution - siltuximab 100mg/vial

Singapore - English - HSA (Health Sciences Authority)

link healthcare singapore pte ltd - siltuximab - injection, powder, lyophilized, for solution - siltuximab 400mg/vial

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - siltuximab 100mg;  ;   - powder for infusion concentrate - 100 mg - active: siltuximab 100mg     excipient: histidine polysorbate 80 sucrose - sylvant is indicated for the treatment of adult patients with multicentric castleman's disease (mcd) who are human immunodeficiency virus (hiv) negative and human herpesvirus-8 (hhv-8) negative.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - siltuximab 400mg;  ;   - powder for infusion concentrate - 400 mg - active: siltuximab 400mg     excipient: histidine polysorbate 80 sucrose - sylvant is indicated for the treatment of adult patients with multicentric castleman's disease (mcd) who are human immunodeficiency virus (hiv) negative and human herpesvirus-8 (hhv-8) negative.